Cargando…
Tissue transglutaminase exacerbates renal fibrosis via alternative activation of monocyte-derived macrophages
Macrophages are important components in modulating homeostatic and inflammatory responses and are generally categorized into two broad but distinct subsets: classical activated (M1) and alternatively activated (M2) depending on the microenvironment. Fibrosis is a chronic inflammatory disease exacerb...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981766/ https://www.ncbi.nlm.nih.gov/pubmed/36864028 http://dx.doi.org/10.1038/s41419-023-05622-5 |
_version_ | 1784900179675054080 |
---|---|
author | Shinoda, Yoshiki Tatsukawa, Hideki Yonaga, Atsushi Wakita, Ryosuke Takeuchi, Taishu Tsuji, Tokuji Tanaka, Miyako Suganami, Takayoshi Hitomi, Kiyotaka |
author_facet | Shinoda, Yoshiki Tatsukawa, Hideki Yonaga, Atsushi Wakita, Ryosuke Takeuchi, Taishu Tsuji, Tokuji Tanaka, Miyako Suganami, Takayoshi Hitomi, Kiyotaka |
author_sort | Shinoda, Yoshiki |
collection | PubMed |
description | Macrophages are important components in modulating homeostatic and inflammatory responses and are generally categorized into two broad but distinct subsets: classical activated (M1) and alternatively activated (M2) depending on the microenvironment. Fibrosis is a chronic inflammatory disease exacerbated by M2 macrophages, although the detailed mechanism by which M2 macrophage polarization is regulated remains unclear. These polarization mechanisms have little in common between mice and humans, making it difficult to adapt research results obtained in mice to human diseases. Tissue transglutaminase (TG2) is a known marker common to mouse and human M2 macrophages and is a multifunctional enzyme responsible for crosslinking reactions. Here we sought to identify the role of TG2 in macrophage polarization and fibrosis. In IL-4-treated macrophages derived from mouse bone marrow and human monocyte cells, the expression of TG2 was increased with enhancement of M2 macrophage markers, whereas knockout or inhibitor treatment of TG2 markedly suppressed M2 macrophage polarization. In the renal fibrosis model, accumulation of M2 macrophages in fibrotic kidney was significantly reduced in TG2 knockout or inhibitor-administrated mice, along with the resolution of fibrosis. Bone marrow transplantation using TG2-knockout mice revealed that TG2 is involved in M2 polarization of infiltrating macrophages derived from circulating monocytes and exacerbates renal fibrosis. Furthermore, the suppression of renal fibrosis in TG2-knockout mice was abolished by transplantation of wild-type bone marrow or by renal subcapsular injection of IL4-treated macrophages derived from bone marrow of wild-type, but not TG2 knockout. Transcriptome analysis of downstream targets involved in M2 macrophages polarization revealed that ALOX15 expression was enhanced by TG2 activation and promoted M2 macrophage polarization. Furthermore, the increase in the abundance of ALOX15-expressing macrophages in fibrotic kidney was dramatically suppressed in TG2-knockout mice. These findings demonstrated that TG2 activity exacerbates renal fibrosis by polarization of M2 macrophages from monocytes via ALOX15. |
format | Online Article Text |
id | pubmed-9981766 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-99817662023-03-04 Tissue transglutaminase exacerbates renal fibrosis via alternative activation of monocyte-derived macrophages Shinoda, Yoshiki Tatsukawa, Hideki Yonaga, Atsushi Wakita, Ryosuke Takeuchi, Taishu Tsuji, Tokuji Tanaka, Miyako Suganami, Takayoshi Hitomi, Kiyotaka Cell Death Dis Article Macrophages are important components in modulating homeostatic and inflammatory responses and are generally categorized into two broad but distinct subsets: classical activated (M1) and alternatively activated (M2) depending on the microenvironment. Fibrosis is a chronic inflammatory disease exacerbated by M2 macrophages, although the detailed mechanism by which M2 macrophage polarization is regulated remains unclear. These polarization mechanisms have little in common between mice and humans, making it difficult to adapt research results obtained in mice to human diseases. Tissue transglutaminase (TG2) is a known marker common to mouse and human M2 macrophages and is a multifunctional enzyme responsible for crosslinking reactions. Here we sought to identify the role of TG2 in macrophage polarization and fibrosis. In IL-4-treated macrophages derived from mouse bone marrow and human monocyte cells, the expression of TG2 was increased with enhancement of M2 macrophage markers, whereas knockout or inhibitor treatment of TG2 markedly suppressed M2 macrophage polarization. In the renal fibrosis model, accumulation of M2 macrophages in fibrotic kidney was significantly reduced in TG2 knockout or inhibitor-administrated mice, along with the resolution of fibrosis. Bone marrow transplantation using TG2-knockout mice revealed that TG2 is involved in M2 polarization of infiltrating macrophages derived from circulating monocytes and exacerbates renal fibrosis. Furthermore, the suppression of renal fibrosis in TG2-knockout mice was abolished by transplantation of wild-type bone marrow or by renal subcapsular injection of IL4-treated macrophages derived from bone marrow of wild-type, but not TG2 knockout. Transcriptome analysis of downstream targets involved in M2 macrophages polarization revealed that ALOX15 expression was enhanced by TG2 activation and promoted M2 macrophage polarization. Furthermore, the increase in the abundance of ALOX15-expressing macrophages in fibrotic kidney was dramatically suppressed in TG2-knockout mice. These findings demonstrated that TG2 activity exacerbates renal fibrosis by polarization of M2 macrophages from monocytes via ALOX15. Nature Publishing Group UK 2023-03-02 /pmc/articles/PMC9981766/ /pubmed/36864028 http://dx.doi.org/10.1038/s41419-023-05622-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Shinoda, Yoshiki Tatsukawa, Hideki Yonaga, Atsushi Wakita, Ryosuke Takeuchi, Taishu Tsuji, Tokuji Tanaka, Miyako Suganami, Takayoshi Hitomi, Kiyotaka Tissue transglutaminase exacerbates renal fibrosis via alternative activation of monocyte-derived macrophages |
title | Tissue transglutaminase exacerbates renal fibrosis via alternative activation of monocyte-derived macrophages |
title_full | Tissue transglutaminase exacerbates renal fibrosis via alternative activation of monocyte-derived macrophages |
title_fullStr | Tissue transglutaminase exacerbates renal fibrosis via alternative activation of monocyte-derived macrophages |
title_full_unstemmed | Tissue transglutaminase exacerbates renal fibrosis via alternative activation of monocyte-derived macrophages |
title_short | Tissue transglutaminase exacerbates renal fibrosis via alternative activation of monocyte-derived macrophages |
title_sort | tissue transglutaminase exacerbates renal fibrosis via alternative activation of monocyte-derived macrophages |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981766/ https://www.ncbi.nlm.nih.gov/pubmed/36864028 http://dx.doi.org/10.1038/s41419-023-05622-5 |
work_keys_str_mv | AT shinodayoshiki tissuetransglutaminaseexacerbatesrenalfibrosisviaalternativeactivationofmonocytederivedmacrophages AT tatsukawahideki tissuetransglutaminaseexacerbatesrenalfibrosisviaalternativeactivationofmonocytederivedmacrophages AT yonagaatsushi tissuetransglutaminaseexacerbatesrenalfibrosisviaalternativeactivationofmonocytederivedmacrophages AT wakitaryosuke tissuetransglutaminaseexacerbatesrenalfibrosisviaalternativeactivationofmonocytederivedmacrophages AT takeuchitaishu tissuetransglutaminaseexacerbatesrenalfibrosisviaalternativeactivationofmonocytederivedmacrophages AT tsujitokuji tissuetransglutaminaseexacerbatesrenalfibrosisviaalternativeactivationofmonocytederivedmacrophages AT tanakamiyako tissuetransglutaminaseexacerbatesrenalfibrosisviaalternativeactivationofmonocytederivedmacrophages AT suganamitakayoshi tissuetransglutaminaseexacerbatesrenalfibrosisviaalternativeactivationofmonocytederivedmacrophages AT hitomikiyotaka tissuetransglutaminaseexacerbatesrenalfibrosisviaalternativeactivationofmonocytederivedmacrophages |